Ophthalmic and Topical Dosage Form New Animal Drugs; Selamectin
other · Food and Drug Administration · Rule · Published 2000-07-21 · Effective 2000-07-21 · 65 FR 45282
Document
Document number
00-18458
Federal Register citation
65 FR 45282
CFR reference
21 CFR 524
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
2000-07-21
Effective date
2000-07-21
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pfizer, Inc. The supplemental NADA provides for topical veterinary prescription use of selamectin solution for the additional indication for control of intestinal hookworm and roundworm infections in cats.